These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 4810052)
1. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates). Bosshard HR; Berger A Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052 [No Abstract] [Full Text] [Related]
2. Specificities of alpha-chymotrypsin and subtilisin Carlsberg. The alpha-acylamido effect in beta-phenylpropionates and their rigid analogs. Matta MS; Staley DD J Biol Chem; 1974 Feb; 249(3):732-7. PubMed ID: 4811900 [No Abstract] [Full Text] [Related]
3. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors. Brömme D; Fittkau S Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035 [TBL] [Abstract][Full Text] [Related]
4. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site. Karasaki Y; Ohno M J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640 [TBL] [Abstract][Full Text] [Related]
5. A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A . Segal DM Biochemistry; 1972 Feb; 11(3):349-56. PubMed ID: 5062058 [No Abstract] [Full Text] [Related]
6. Interactions of alpha-chymotrypsin and Carlsberg subtilisin with methyl N alpha-acetyl-2-(alkylthio)-L-tryptophanoates. Yoshizumi K; Kamiyama K; Shieh TC; Tanaka S; Ohno M J Biochem; 1986 Nov; 100(5):1201-6. PubMed ID: 3546277 [TBL] [Abstract][Full Text] [Related]
7. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin. Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128 [No Abstract] [Full Text] [Related]
8. Subtilisin-catalyzed hydrolysis of peptide methyl esters. Philipp M; Bender ML FEBS Lett; 1974 Jun; 42(3):282-4. PubMed ID: 4854515 [No Abstract] [Full Text] [Related]
9. -Chymotrypsin: what can we learn about catalysis from x-ray diffraction? Henderson R; Wright CS; Hess GP; Blow DM Cold Spring Harb Symp Quant Biol; 1972; 36():63-70. PubMed ID: 4508173 [No Abstract] [Full Text] [Related]
10. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study. Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573 [TBL] [Abstract][Full Text] [Related]
11. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin. Pietrusewicz E; Sieńczyk M; Oleksyszyn J J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056 [TBL] [Abstract][Full Text] [Related]
12. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors. Segal DM; Powers JC; Cohen GH; Davies DR; Wilcox PE Biochemistry; 1971 Sep; 10(20):3728-38. PubMed ID: 5107010 [No Abstract] [Full Text] [Related]
13. Reaction of azapeptides with chymotrypsin-like enzymes. New inhibitors and active site titrants for chymotrypsin A alpha, subtilisin BPN', subtilisin Carlsberg, and human leukocyte cathepsin G. Gupton BF; Carroll DL; Tuhy PM; Kam CM; Powers JC J Biol Chem; 1984 Apr; 259(7):4279-87. PubMed ID: 6368557 [TBL] [Abstract][Full Text] [Related]
14. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. McPhalen CA; James MN Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813 [TBL] [Abstract][Full Text] [Related]
15. Probing the specificity of the S1 binding site of subtilisin Carlsberg with boronic acids. Seufer-Wasserthal P; Martichonok V; Keller TH; Chin B; Martin R; Jones JB Bioorg Med Chem; 1994 Jan; 2(1):35-48. PubMed ID: 7922119 [No Abstract] [Full Text] [Related]
16. Preparation and kinetic properties of a new form of chymotrypsin which is active at alkaline pH: 1 -chymotrypsin. Valenzuela P; Bender ML J Biol Chem; 1973 Jul; 248(14):4909-14. PubMed ID: 4736884 [No Abstract] [Full Text] [Related]
18. Mechanism of chymotrypsin. Structure, reactivity, and nonproductive binding relationships. Fastrez J; Fersht AR Biochemistry; 1973 Mar; 12(6):1067-74. PubMed ID: 4688860 [No Abstract] [Full Text] [Related]
19. Comparative biochemistry of penguin egg-white proteins. I. Ovomucoids: composition and inhibitory activities for trypsin, alpha-chymotrypsin and subtilisin. Osuga DT; Bigler JC; Uy RL; Sjöberg L; Feeney RE Comp Biochem Physiol B; 1974 Aug; 48(4):519-33. PubMed ID: 4842054 [No Abstract] [Full Text] [Related]
20. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes. Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]